• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Better outcome with haploidentical over ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1038/s41409-017-0018-z
PMID :
29330405
Permalink :
http://hdl.handle.net/20.500.12210/4653
Title :
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Author(s) :
Gauthier, Jordan [Auteur]
Poire, Xavier [Auteur]
Gac, Anne-Claire [Auteur]
Leclerc, Mathieu [Auteur]
Guillaume, Thierry [Auteur]
Chalandon, Yves [Auteur]
Nguyen, Stephanie [Auteur]
Forcade, Edouard [Auteur]
Regny, Caroline [Auteur]
Bay, Jacques-Olivier [Auteur]
Bazarbachi, Ali [Auteur]
Rohrlich, Pierre-Simon [Auteur]
Huynh, Anne [Auteur]
Farhi, Jonathan [Auteur]
Marchand, Tony [Auteur]
Malfuson, Jean-Valere [Auteur]
Pilorge, Sylvain [Auteur]
Labussiere-Wallet, Helene [Auteur]
Renard, Cecile [Auteur]
Fornecker, Luc-Matthieu [Auteur]
Detrait, Marie [Auteur]
Dulery, Remy [Auteur]
Delage, Jeremy [Auteur]
Menard, Anne-Lise [Auteur]
Charbonnier, Amandine [Auteur]
Nelken, Brigitte [Auteur]
Jubert, Charlotte [Auteur]
Suarez, Felipe [Auteur]
Peffault De Latour, Regis [Auteur]
Beguin, Yves [Auteur]
Schoemans, Helene [Auteur]
Blaise, Didier [Auteur]
Yakoub Agha, Ibrahim [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Journal title :
Bone marrow transplantation
Abbreviated title :
Bone Marrow Transplant.
Publication date :
2018-01-12
ISSN :
1476-5365
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The question of the best donor type between haploidentical (HAPLO) and matched-related donors (MRD) for patients with advanced HL receiving an allogeneic hematopoietic cell transplantation (allo-HCT) is still debated. ...
Show more >
The question of the best donor type between haploidentical (HAPLO) and matched-related donors (MRD) for patients with advanced HL receiving an allogeneic hematopoietic cell transplantation (allo-HCT) is still debated. Given the lack of data comparing these two types of donor in the setting of non-myeloablative (NMA) or reduced-intensity (RIC) allo-HCT, we performed a multicentre retrospective study using graft-vs.-host disease-free relapse-free survival (GRFS) as our primary endpoint. We analysed the data of 151 consecutive HL patients who underwent NMA or RIC allo-HCT from a HAPLO (N = 61) or MRD (N = 90) between January 2011 and January 2016. GRFS was defined as the probability of being alive without evidence of relapse, grade 3-4 acute GVHD or chronic GVHD. In multivariable analysis, MRD donors were independently associated with lower GRFS compared to HAPLO donors (HR = 2.95, P < 0.001). Disease status at transplant other than CR was also associated with lower GRFS in multivariable analysis (HR = 1.74, P = 0.01). In addition, the administration of ATG was independently linked to higher GRFS (HR = 0.52, P = 0.009). In summary, we observed significantly higher GRFS in HL patients receiving an allo-HCT using the HAPLO PT-Cy platform compared to MRD.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Collections :
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Research team(s) :
Immunity, inflammation and fibrsis in auto and allo-reactivity
Submission date :
2019-03-01T14:18:00Z
Université de Lille

Mentions légales
Université de Lille © 2017